Ming Yan Ph.D.
Net Worth

Last updated:

What is Ming Yan Ph.D. net worth?

The estimated net worth of Dr. Ming Yan Ph.D. is at least $30,597,426 as of 18 Nov 2024. He owns shares worth $24,193,548 as insider, has earned $5,382,288 from insider trading and has received compensation worth at least $1,021,590 in Cytek Biosciences, Inc..

What is the salary of Ming Yan Ph.D.?

Dr. Ming Yan Ph.D. salary is $340,530 per year as Chief Technology Officer & Director in Cytek Biosciences, Inc..

How old is Ming Yan Ph.D.?

Dr. Ming Yan Ph.D. is 62 years old, born in 1963.

What stocks does Ming Yan Ph.D. currently own?

As insider, Dr. Ming Yan Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Cytek Biosciences, Inc. (CTKB) Chief Technology Officer & Director 5,988,502 $4.04 $24,193,548

What does Cytek Biosciences, Inc. do?

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Ming Yan Ph.D. insider trading

Cytek Biosciences, Inc.

Dr. Ming Yan Ph.D. has made 33 insider trades between 2022-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 62,456 units of CTKB stock on 7 Mar 2022. As of 18 Nov 2024 he still owns at least 5,988,502 units of CTKB stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 1,981 N/A N/A
Option
Common Stock 7,363 N/A N/A
Option
Restricted Stock Units 1,981 N/A N/A
Option
Restricted Stock Units 7,363 N/A N/A
Option
Restricted Stock Units 5,525 N/A N/A
Option
Common Stock 5,525 N/A N/A
Option
Common Stock 5,525 N/A N/A
Option
Common Stock 1,981 N/A N/A
Option
Common Stock 7,363 N/A N/A
Option
Restricted Stock Units 7,363 N/A N/A
Option
Restricted Stock Units 1,981 N/A N/A
Option
Restricted Stock Units 5,525 N/A N/A
Option
Restricted Stock Units 3,683 N/A N/A
Option
Restricted Stock Units 1,981 N/A N/A
Option
Common Stock 3,683 N/A N/A
Option
Common Stock 4,908 N/A N/A
Option
Common Stock 1,981 N/A N/A
Option
Restricted Stock Units 4,980 N/A N/A
Sale
Common Stock 20,000 $5.87 $117,400
Sale
Common Stock 1,500 $7 $10,500
Sale
Common Stock 400 $7.01 $2,804
Sale
Common Stock 20,000 $6.71 $134,200
Sale
Common Stock 20,000 $6.77 $135,400
Option
Restricted Stock Units 9,817 N/A N/A
Option
Common Stock 9,817 N/A N/A
Option
Common Stock 1,981 N/A N/A
Option
Restricted Stock Units 1,981 N/A N/A
Sale
Common Stock 20,000 $9.43 $188,600
Sale
Common Stock 20,000 $6.03 $120,600
Option
Restricted Stock Units 1,981 N/A N/A
Option
Restricted Stock Units 7,363 N/A N/A
Option
Common Stock 1,981 N/A N/A
Option
Common Stock 7,363 N/A N/A
Sale
Common Stock 20,000 $4.8 $96,000
Sale
Common Stock 20,000 $6.49 $129,800
Sale
Common Stock 20,000 $8.07 $161,400
Option
Common Stock 7,363 N/A N/A
Option
Restricted Stock Units 7,363 N/A N/A
Option
Restricted Stock Units 1,981 N/A N/A
Option
Common Stock 1,981 N/A N/A
Sale
Common Stock 20,000 $8.76 $175,200
Sale
Common Stock 20,000 $8.18 $163,600
Sale
Common Stock 20,000 $7.19 $143,800
Option
Restricted Stock Units 4,908 N/A N/A
Option
Common Stock 4,908 N/A N/A
Option
Common Stock 1,981 N/A N/A
Option
Restricted Stock Units 1,981 N/A N/A
Sale
Common Stock 20,000 $9.71 $194,200
Sale
Common Stock 20,000 $9.29 $185,800
Option
Restricted Stock Units 1,981 N/A N/A
Option
Common Stock 1,981 N/A N/A
Sale
Common Stock 20,000 $10.94 $218,800
Sale
Common Stock 897 $13.53 $12,136
Sale
Common Stock 1,081 $13.5 $14,594
Sale
Common Stock 11 $13.51 $149
Sale
Common Stock 20,000 $11.03 $220,600
Sale
Common Stock 20,000 $10.38 $207,600
Sale
Common Stock 20,000 $14.66 $293,200
Option
Common Stock 1,981 N/A N/A
Option
Restricted Stock Units 1,981 N/A N/A
Sale
Common Stock 20,000 $14.42 $288,400
Sale
Common Stock 20,000 $12.42 $248,400
Sale
Common Stock 20,000 $13.62 $272,400
Option
Restricted Stock Units 1,981 N/A N/A
Option
Common Stock 1,981 N/A N/A
Sale
Common Stock 20,000 $11.83 $236,600
Sale
Common Stock 20,000 $10.06 $201,200
Option
Restricted Stock Units 2,642 N/A N/A
Sale
Common Stock 20,000 $9.92 $198,400
Option
Common Stock 2,642 N/A N/A
Sale
Common Stock 20,000 $10.34 $206,800
Sale
Common Stock 20,000 $11.64 $232,800
Option
Common Stock 10,555 $0.92 $9,711
Option
Stock Option (Right to Buy) 62,456 $0.25 $15,614
Option
Stock Option (Right to Buy) 10,555 $0.92 $9,711
Option
Common Stock 62,456 $0.25 $15,614
Sale
Common Stock 20,000 $13.44 $268,800
Sale
Common Stock 14,706 $15.01 $220,737
Sale
Common Stock 5,294 $15.37 $81,369

Cytek Biosciences key executives

Cytek Biosciences, Inc. executives and other stock owners filed with the SEC: